Among these, we found that loss-of-function of Neurofibromin 2 (Nf2) interacts with mutant RAS to initiate tumor formation independent of Trp53 status, highlighting again that as seen in patient data, RAS mutant cells do not strictly rely on Trp53 loss to initiate ICC. Here, NF2 is linked to neoplasm.